Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study

2004 ◽  
Vol 19 (4) ◽  
pp. 241-248 ◽  
Author(s):  
Malcolm Lader ◽  
Karina Stender ◽  
Vera Bürger ◽  
Rico Nil
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Fixed Dose ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Dose Study

scholarly journals A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial ofParoxetine in Children and Adolescents With Social Anxiety Disorder

2004 ◽  
Vol 61 (11) ◽  
pp. 1153 ◽  
Author(s):  
Karen Dineen Wagner ◽  
Ray Berard ◽  
Murray B. Stein ◽  
Erica Wetherhold ◽  
David J. Carpenter ◽  
...  
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Children And Adolescents ◽  
Social Anxiety Disorder ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

A 24-Week Randomized, Double-Blind, Placebo-Controlled Study of Escitalopram for the Prevention of Generalized Social Anxiety Disorder

2005 ◽  
Vol 66 (10) ◽  
pp. 1270-1278 ◽  
Author(s):  
Stuart A. Montgomery ◽  
Rico Nil ◽  
Natalie Dürr-Pal ◽  
Henrik Loft ◽  
Jean-Philippe Boulenger
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

A Randomized, Double-Blind, Fixed-Dose Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Anxiety Disorder

2002 ◽  
Vol 63 (1) ◽  
pp. 66-74 ◽  
Author(s):  
Michael R. Liebowitz ◽  
Murray B. Stein ◽  
Manuel Tancer ◽  
David Carpenter ◽  
Rosemary Oakes ◽  
...  
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Fixed Dose ◽  
Double Blind ◽  
Dose Comparison
Sign in / Sign up

Export Citation Format

Share Document